#Trade Shows & Events
Poclight at ADLM 2025: Empowering Global Precision Diagnostics with "Mini Chemiluminescence"
Poclight C5000 display at ADLM (Chicago)
The 77th Annual Scientific Meeting and Clinical Lab Expo (ADLM 2025), formerly known as AACC, was held from July 29–31, 2025, in Chicago, USA. As one of the most influential and largest global events in clinical diagnostics, ADLM brings together thousands of experts, healthcare institutions, and diagnostic distributors from around the world. The event serves as a vital barometer for innovation and global market trends in in-vitro diagnostics (IVD).
A Global Hub of Innovation and Collaboration
Each year, ADLM attracts more than 20,000 attendees and over 800 exhibitors. The event connects key players from clinical laboratories, hospital administrators, academic researchers, and international distributors. More than just a product showcase, ADLM is a pivotal platform for forming global partnerships and driving expansion into international markets.
Poclight Shines at ADLM: "Small Analyzer, Big Impact"
At ADLM 2025, Poclight captured attention with its cutting-edge innovations in compact chemiluminescence systems. Under the theme “Linking Global Diagnostics with Mini CLIA,” Poclight demonstrated how its next-generation platform redefines flexibility and performance in modern diagnostics.
Highlight 1: Compact and Powerful — The C5000 Series
The C5000 analyzer, with a footprint no larger than an A4 paper and weighing only 6 kg, integrates the precision of chemiluminescence with the ease of point-of-care testing (POCT). Despite its small size, it delivers uncompromised performance:
1.High sensitivity, rapid results, and minimal user operation
2.No separation or washing module required; no liquid systems or extra consumables beyond reagents
3.Designed for portability and space efficiency
This unique design attracted widespread interest from international visitors looking for agile diagnostic solutions.
Highlight 2: Broad and Growing Test Menu
The C5000 supports a rich and expanding portfolio of assays, including:Thyroid function;Sex hormones;
Cardiac markers;Platelet function;Metabolic and inflammatory markers
These single-use lyophilized reagent kits are designed for long-term stability at room temperature, enabling reliable performance and easier logistics—especially in remote or resource-limited settings. The reagents are benchmarked against international standards and continue to earn trust from users worldwide.
Highlight 3: Multi-Platform, Multi-Scenario Applications
Human healthcare: Tailored for emergency departments, ICUs, operating rooms, primary care, and health check centers—offering timely and precise diagnostics at the point of need.
Veterinary diagnostics: Bringing human-grade quality to animal care, with rapid and specific markers for inflammation, endocrine, and cardiac conditions in pets.
Global Strategy, Local Action
Poclight’s participation in ADLM 2025 is a key milestone in its global strategy. Leveraging this premier international platform, Poclight aims to:
Enhance global brand visibility
Showcase the strengths of "Mini CLIA" technology
Build strategic partnerships with top-tier distributors, healthcare networks, and research institutions worldwide
This global outreach is accelerating the adoption of Poclight’s technology in Europe, North America, and emerging markets. By empowering decentralized diagnostics with high-performance, portable solutions, Poclight is reshaping the future of clinical testing—making precision diagnostics more accessible than ever before.
